Sangamo BioSciences has initiated a Phase I clinical trial for its
novel therapy for diabetic neuropathy that is designed to protect
and stimulate the regeneration of peripheral nerve function in
diabetics suffering from peripheral...
Innodia are to initiate a phase I trial of its lead drug candidate
for the treatment of type 2 diabetes with a view to bringing this
novel drug to market and the 170 million people affected by the
disease, a number that is expected...
Drug therapies for sufferers of diabetes may become a thing of the
past as UK doctors performed a groundbreaking cell transplant
technique on a patient making him the first person to be "cured" of
the illness.
US scientists have demonstrated that by knocking out two key
signals in liver cells causes diabetes. These findings pave the way
for drug strategies to boost these two different signals and treat
the different metabolic components...
Pre-school youngsters with type I diabetes can be treated as
successfully with insulin pumps as with daily injections,
researchers at the Indiana University School of Medicine report.
The lead agent in a new class of drugs for the treatment of
diabetes - Novartis' LAF-237 - seems to improve glucose control
without the weight gain associated with other orally-active drugs
for this common disease, reports Phil...
A natural mutation of a gene that helps regulate the reactivity of
the immune system is a major contributor to type 1 diabetes,
researchers have found, writes Wai Lang Chu..
There has been a steady increase in the number of diabetes-related
R&D projects in recent years, and one area of particular
interest is the pulmonary delivery of insulin, says a new report